BofA analyst Michael Ryskin raised the firm’s price target on Idexx Laboratories (IDXX) to $535 from $475 and keeps a Neutral rating on the shares after the company reported a “strong” Q4 ...

Full-year EPS for 2024 reached $10.67, up 12% comparably. IDEXX introduced key innovations, including the launch of IDEXX inVue Dx, a slide-free Point-of-Care analyzer, and the IDEXX Cancer Dx ...

Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

Idexx Laboratories (NASDAQ:IDXX) just wrapped up 2024 on a high note, crushing analyst expectations with Q4 revenue hitting $954 millionoutpacing estimates of $935 million. EPS landed at $2.62 ...

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 ...

An international coalition of law enforcement agencies took down two hacking forums that had more than 10 million users, according to Europol, one of the agencies involved in the operation.

Across the recent three months, 4 analysts have shared their insights on IDEXX Laboratories (NASDAQ:IDXX), expressing a variety of opinions spanning from bullish to bearish. The table below ...

UPDATE 1/30: According to the Justice Department, Cracked[.]io helped cybercriminals target at least 17 million US victims. Original Story: The FBI has seized a pair of internet forums dedicated ...

Early data shows IDEXX Cancer Dx testing can detect lymphoma before clinical signs are present, 5 supporting its utility in routine preventive care for at-risk dogs. "Building on over 40 years of ...